EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy

Tuan Hiep Tran, Thi Thu Phuong Tran

International Immunopharmacology · 2024-12 · 142 · 113085

DOI: 10.1016/j.intimp.2024.113085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Tuan Hiep Tran und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, PHENIKAA University, Hanoi 12116, Vietnam. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Immunogenic Cell Death, Nanoparticles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 125 Literaturangaben. Gefördert von: National Foundation for Science and Technology Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death (ICD) encompasses various forms of cell death modalities, including apoptosis, necroptosis, ferroptosis, and pyroptosis. It arises from a harmonious interplay of adjuvant (damage-associated molecular patterns-DAMPs and chemokines/cytokines) and antigenicity (tumor-associated antigens-TAA) to induce immune-reaction toward cancer cells. Inducing ICD stands out as a promising approach in cancer immunotherapy, capable of directly eliminating cancer cells and of eliciting enduring antitumor immune responses. Conventional tumor therapies like radiation therapy, photodynamic therapy, and chemotherapy can also induce ICD which could amplify their activities. The development of effective ICD inducers like nano-systems is crucial for ensuring safe and efficacious immunotherapy. Nanoparticles hold considerable promise in cancer therapy, offering enhanced therapeutic outcomes and mitigated side effects. They could be the capacity to adjust systemic biodistribution, augment the accumulation of therapeutic agents at the intended site and protect active agents from the complexity of human biofluid. This review aims to outline the role of nanoparticles in triggering ICD for cancer immunotherapy that potentially pave the way for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyImmunogenic Cell DeathNanoparticlesHumansAnimals

Stichwörter der Autor:innen

CancerChemotherapyImmunogenic cell deathImmunotherapyPhototherapyRadiotherapy

Autor:innen und Institutionen

  • Faculty of Pharmacy, PHENIKAA University, Hanoi 12116, Vietnam.
  • Department of Life Sciences, University of Science and Technology of Hanoi (USTH), Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam. Electronic address: tran-thi-thu.phuong@…

Förderung

  • National Foundation for Science and Technology Development

Zitieren

APA

Hiep Tran, T., & Thu Phuong Tran, T. (2024). Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy. International Immunopharmacology, 142, 113085. https://doi.org/10.1016/j.intimp.2024.113085

Vancouver

Hiep Tran T, Thu Phuong Tran T. Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy. International Immunopharmacology. 2024;142:113085. doi:10.1016/j.intimp.2024.113085

BibTeX
@article{HiepTran2024,
  author = {Hiep Tran, Tuan and Thu Phuong Tran, Thi},
  title = {Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {142},
  pages = {113085},
  doi = {10.1016/j.intimp.2024.113085}
}
Kostenlos starten →